Hyperuricemia and Gout: Mechanisms and Morbidity

Session Type: ACR Clinical Symposia
Tuesday, November 8, 2011: 1:00 PM-2:00 PM
W375b (McCormick Place West)
Clinical  Clinical Practice  SessionSelect

Session Overview:
Gout is the most common form of inflammatory arthritis in men over the age of 50.  Its incidence is rising due to an increasing body mass index in the population.  Recent data has demonstrated that hyperuricemia without gout has health consequences.  The purpose of this discussion will be to review and update for the clinician on recent finding on the pathogenesis and consequences of hyperuricemia and gout.

Upon completion of this session, participants should be able to:

  • explain the mechanisms by which hyperuricemia leads to gouty arthritis
  • discuss the possible long term consequences of sustained hyperuricemia
  • outline treatment options for patients with hyperuricemia and gout with emphasis on newer therapies

Moderator: Gregory C. Gardner, MD, University of Washington
Talks:
1:00 PM
Michael H. Pillinger, NYU Hospital for Joint Diseases, New York, NY
See more of: ACR Clinical Symposia

To see other sessions for this day, use the date buttons to the left.